« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 67, Issue 5
, Pages 1309-1317
, 1 April 2007
Impact of Intensity-Modulated Radiotherapy on Health-Related Quality of Life for Head and Neck Cancer Patients: Matched-Pair Comparison with Conventional Radiotherapy
References
- Patients with head and neck cancer cured by radiation therapy: A survey of the dry mouth syndrome in long-term survivors. Head Neck. 2002;24:737–747
- Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22:69–76
- Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol. 2004;70:189–198
- [Intensity-modulated radiation therapy for head and neck cancers with bilateral irradiation of the neck: Preliminary results]. Cancer Radiother. 2004;8:134–147
- The role of intensity modulated radiation therapy for favorable stage tumor of the nasal cavity or ethmoid sinus. Am J Clin Oncol. 2005;28:474–478
- Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys. 2003;56:158–168
- Implications of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy. Int J Oral Maxillofac Surg. 2005;34:114–121
- The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376
- Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: The QLQ=C30 (+ 3). J Clin Oncol. 1998;16:1188–1196
- Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol. 1999;17:1008–1019
- for the EORTC Quality of Life Group A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Cancer. 2000;36:1796–1807
- Assessing quality of life in patients with head and neck cancer: Cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg. 2000;126:459–467
- The EORTC QLQ-C30 Scoring Manual. 3rd ed.. Brussels, Belgium: European Organisation for Research and Treatment of Cancer; 2001;
- Using reference data on quality of life—The importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer. 1998;34:1381–1389
- . Relationship between prevalence rate ratios and odds ratios in cross-sectional studies. Int J Epidemiol. 1997;26:220–223
- Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients. Cancer Detect Prev. 2003;27:305–310
- Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003;57:61–70
- Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:663–673
- Quality of life in long-term survivors of oropharynx carcinoma. Int J Radiat Oncol Biol Phys. 2002;54:742–751
- Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: A cross-sectional study. BMC Gastroenterol. 2003;3:33
- Quality of life among disease-free survivors of rectal cancer. J Clin Oncol. 2004;22:354–360
- . A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer. Health Qual Life Outcomes. 2006;4:17
- Correlates of health-related quality of life in upper aerodigestive tract cancer patients. Qual Life Res. 1998;7:713–722
- . Assessing quality of life in head and neck cancer. Qual Life Res. 1992;1:5–17
- Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: The importance of the target volume. Int J Radiat Oncol Biol Phys. 1999;45:47–52
- Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck. 2001;23:389–398
- Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: A prospective examination. J Clin Oncol. 1999;17:1020–1028
- Health-related quality of life three years after diagnosis of head and neck cancer—A longitudinal study. Head Neck. 2001;23:113–125
- A prospective study of quality of life in head and neck cancer patients (Part II: Longitudinal data). Laryngoscope. 2001;111:1440–1452
- Quality of life and head and neck cancer: A 5 year prospective study. Laryngoscope. 2005;115:2183–2192
- Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol. 2001;37:84–93
- Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report. Int J Radiat Oncol Biol Phys. 2005;63:725–731
- Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577–587
- Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys. 2001;51:938–946
- A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys. 2001;49:907–916
- Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys. 2004;58:175–184
Supported by the French League Against Cancer (Meuse Department).Conflict of interest: none.
PII: S0360-3016(06)03489-4
doi: 10.1016/j.ijrobp.2006.11.012
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 67, Issue 5
, Pages 1309-1317
, 1 April 2007
